Global Antimicrobial Peptides Service Market Growth (Status and Outlook) 2023-2029

Global Antimicrobial Peptides Service Market Growth (Status and Outlook) 2023-2029

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

LPI (LP Information)' newest research report, the “Antimicrobial Peptides Service Industry Forecast” looks at past sales and reviews total world Antimicrobial Peptides Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Antimicrobial Peptides Service sales for 2023 through 2029. With Antimicrobial Peptides Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimicrobial Peptides Service industry.

This Insight Report provides a comprehensive analysis of the global Antimicrobial Peptides Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimicrobial Peptides Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimicrobial Peptides Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimicrobial Peptides Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimicrobial Peptides Service.

The global Antimicrobial Peptides Service market size is projected to grow from US$ 5 million in 2022 to US$ 6 million in 2029; it is expected to grow at a CAGR of 3.4% from 2023 to 2029.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Peptides Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
AMPs Synthesis Service
AMPs Activity Assay Service
AMPs Development
AMPs Modification and Design

Segmentation by application
Enterprise
Factory

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Profacgen
LifeTein
GenScript
CPC Scientific
Pepscan
Creative Biolabs
Creative Peptides
Bachem
Creative Proteomics

Please note: The report will take approximately 2 business days to prepare and deliver.